Institute of Medical Immunology, Affiliated Hospital of Jiangsu University, Zhenjiang, China; Department of Laboratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Institute of Medical Immunology, Affiliated Hospital of Jiangsu University, Zhenjiang, China; Department of Laboratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
J Autoimmun. 2023 Jul;138:103049. doi: 10.1016/j.jaut.2023.103049. Epub 2023 May 23.
As a ligand-activated transcription factor, the aryl hydrocarbon receptor (AhR) is activated by structurally diverse ligands derived from the environment, diet, microorganisms, and metabolic activity. Recent studies have demonstrated that AhR plays a key role in modulating both innate and adaptive immune responses. Moreover, AhR regulates innate immune and lymphoid cell differentiation and function, which is involved in autoimmune pathogenesis. In this review, we discuss recent advances in understanding the mechanism of activation of AhR and its mediated functional regulation in various innate immune and lymphoid cell populations, as well as the immune-regulatory effect of AhR in the development of autoimmune diseases. In addition, we highlight the identification of AhR agonists and antagonists that may serve as potential therapeutic targets for the treatment of autoimmune disorders.
作为一种配体激活的转录因子,芳香烃受体(AhR)可被环境、饮食、微生物和代谢活动来源的结构多样的配体激活。最近的研究表明,AhR 在调节先天和适应性免疫反应方面发挥着关键作用。此外,AhR 调节先天免疫和淋巴样细胞分化和功能,这与自身免疫发病机制有关。在这篇综述中,我们讨论了近年来在理解 AhR 激活机制及其在各种先天免疫和淋巴样细胞群中的介导功能调节方面的进展,以及 AhR 在自身免疫性疾病发展中的免疫调节作用。此外,我们强调了 AhR 激动剂和拮抗剂的鉴定,它们可能成为治疗自身免疫性疾病的潜在治疗靶点。